SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-012723
Filing Date
2023-04-13
Accepted
2023-04-13 16:36:09
Documents
5
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A dsgn-def14a-2023.htm DEF 14A 1062651
2 GRAPHIC img131554364_0.jpg GRAPHIC 16766
3 GRAPHIC img131554364_1.jpg GRAPHIC 16766
4 GRAPHIC img131554364_2.jpg GRAPHIC 82091
5 GRAPHIC img131554364_3.jpg GRAPHIC 45258
  Complete submission text file 0000950170-23-012723.txt   1285748
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40288 | Film No.: 23818795
SIC: 2834 Pharmaceutical Preparations